Search 

Based at St Georges University of London, Richmond Pharmacology Limited is one of 14 MHRA accredited UK phase one units specialising in early phase Adaptive Studies (including First-In-Human), Cardiac Safety/Intensive ECG/Thorough QT studies, Ethnic Bridging studies and Patient Studies.

Our Principal Investigators offer peer-to-peer advice, intelligent protocol design and development and expert know-how for global regulatory requirements.Our streamlined methods ensure we deliver each milestone right on cue, with no extensions and no extra cost.